Acrx final deadline: bronstein, gewirtz & grossman, llc reminds acelrx pharmaceuticals, inc. shareholders of class action and lead plaintiff deadline: august 9, 2021

New york, new york--(newsfile corp. - august 9, 2021) - bronstein, gewirtz & grossman, llc notifies investors that a class action lawsuit has been filed against acelrx pharmaceuticals, inc. ("acelrx" or "the company") (nasdaq: acrx) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired acelrx securities between march 17, 2020 and february 12, 2021, (the "class period"). such investors are encouraged to join this case by visiting the firm's site:...
ACRX Ratings Summary
ACRX Quant Ranking